Dr. Tibor Jozsef Kovacsovics, MD

Dr. Kovacsovics practices at City of Hope Cancer Center Phoenix in Goodyear, Arizona, part of City of Hope.

Dr. Kovacsovics' NPI, 1396750899, was assigned on July 31, 2006. Dr. Kovacsovics holds Oregon license MD24797.

Dr. Kovacsovics' primary practice is City of Hope Cancer Center Phoenix, at 14200 West Celebrate Life Way, Goodyear, AZ 85338 in Maricopa County. The practice phone is (623) 207-3000.

Dr. Kovacsovics' primary practice is City of Hope Cancer Center Phoenix in Goodyear, Arizona, part of City of Hope. Dr. Kovacsovics is also affiliated with OHSU Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Kovacsovics to 2 more medical groups and 1 other site, each named with a free account. Dr. Kovacsovics' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kovacsovics practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kovacsovics' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kovacsovics is licensed in Oregon.

CMS data shows 145 Medicare services from Dr. Kovacsovics across 4 procedure codes in 2024, for 38 Medicare patients. Medicare paid $12,602 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Dr. Kovacsovics in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high cholesterol, and 71% have arthritis. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kovacsovics' median patient age at 71, with 39% women.

In 2024, Dr. Kovacsovics wrote 216 Medicare Part D claims for 27 patients. 72% of them were for generic drugs. CMS names the drug for 100 of them, across 6 drugs with 11 or more claims each, at $55,164 in total drug cost. In 2023, CMS named 167 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Kovacsovics for performance year 2024, reported as part of a group. Dr. Kovacsovics accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kovacsovics as offering telehealth.

CMS Open Payments shows 394 general payments to Dr. Kovacsovics from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Amgen Inc. paid the most, $60,736. It also lists 10 research payments totaling $11,075 from 2017 to 2024.